PR Newswire
PHILADELPHIA, PA — (PRNewswire) — HealthVerity, Inc., the leader in Identity, Privacy, Governance, and Exchange (IPGE) for real-world data, today announced that it has been awarded a contract with the Centers for Disease Control and Prevention (CDC) to provide a large-scale, fully interoperable, real-world dataset to advance a wide range of COVID-19 research, decision making, and public health impact objectives. Using Privacy-Preserving Record Linkage (PPRL), the HealthVerity data asset securely links de-identified patient-level data across medical and pharmacy claims, chargemaster, electronic medical records, and lab data, including genomic sequencing of COVID-19 variants, to generate comprehensive and longitudinal patient histories without sharing personally identifiable information.
The goal of this contract is to provide the CDC with a real-world dataset that is uniquely suited to provide novel insights into new and emerging priority questions related to SARS-CoV-2 variants, vaccinations, testing, re-infection, health impact, natural history, and the long-term effects of COVID-19. The data has high impact potential for CDC’s COVID-19 response and surveillance efforts because it offers CDC scientists the opportunity to conduct complex analyses and develop use cases on disease patterns, progression, and health outcomes. Leveraging its HealthVerity IPGE platform, including the nation’s largest privacy-protected healthcare and consumer data ecosystem, HealthVerity is assembling the largest, fully interoperable, real-world COVID-19 data asset ever acquired by the CDC.
“HealthVerity is proud to support the CDC in leveraging strategic data assets on its quest to understand the broad impact of COVID-19 on patients, healthcare systems, and communities,” said Andrew Kress, CEO at HealthVerity. “We are pleased that our expertise in patient identity resolution and privacy management combined with the broad cross-sectional healthcare and consumer data we manage on behalf of our data partners uniquely enables us to deliver a level of dimensionality for evidence generation that is critical to this major public health endeavor.”
In addition to COVID-19, the agreement provides the CDC with access to timely and comprehensive data on other key therapeutic areas such as viral hepatitis and HIV and the impact on key demographic groups, all in a privacy-protected, HIPAA-compliant manner.
HealthVerity has a history of serving key governmental health agencies to support public health initiatives. Most recently, HealthVerity supported the National Cancer Institute (NCI) for a groundbreaking study of SARS-CoV-2 antibodies in February 2021, announced a research contract with the U.S. Food and Drug Administration (FDA) to support COVID-19 clinical study and treatment opportunities in June 2020 and was awarded a PPRL contract for COVID-19 vaccine data with the Department of Health and Human Services (HHS) in November 2020.
Pharmaceutical manufacturers, payers, and government organizations have partnered with HealthVerity to solve some of their most complicated use cases through transformative technologies and real-world data infrastructure. The HealthVerity IPGE platform, based on the foundational elements of Identity, Privacy, Governance, and Exchange, enables the discovery of real-world data across the broadest healthcare data ecosystem, the building of more complete and accurate patient journeys and the ability to power best-in-class analytics and applications with flexibility and ease. Together with our partners, HealthVerity has built the modern way to data for the health insights economy. To learn more about the HealthVerity IPGE platform, visit www.healthverity.com.
Jen Kaczmarczyk
Vice President of Marketing
jkaczmarczyk@healthverity.com
Complete the form to explore how synchronizing transformational technologies with the nation’s largest real-world data ecosystem can fundamentally advance the science.
PHILADELPHIA, PA — (PRNewswire) — Today HealthVerity announced an agreement with Janssen Research & Development, LLC (Janssen) to provide access to the HealthVerity IPGE platform, the largest linked real-world data ecosystem in the US, to further facilitate critical research and development activities. Prior work between HealthVerity and Janssen in data science highlights a broad set of R&D use cases, including:
“We’ve seen the need for real-time RWD to increase dramatically in the wake of COVID-19. The use of this data will continue to accelerate with the expanded focus on RWD to support research and development and regulatory decision making,” said Andrew Kress, CEO at HealthVerity. “In order to support this shift, our clients and data partners need us to help solve the challenge of how to apply this data at scale in a transformative way. The HealthVerity Identity, Privacy, Governance and Exchange (IPGE) platform provides access to record-level data, giving our clients the flexibility to run their own cutting-edge RWE and Data Science analytics and applications on numerous projects at once. We are pleased to collaborate with Janssen’s leading-edge R&D Data Science organization to put this capability into practice.”
The HealthVerity IPGE platform, integrated technology and RWD infrastructure – driven by identity, privacy, governance and exchange – enables organizations to connect and directly access the largest de-identified and privacy-compliant linked real-world dataset of 330 million US patients across the broadest network of data sources, including Medical and Pharmacy Claims, Electronic Health Records (EHR), Labs and Consumer data. The integrated multi-modal linkage capabilities of RWD to clinical trial patients allows the creation of longitudinal patient journeys supporting numerous use cases including Long Term Follow Up (LTFU) and Phase 4 studies.
Pharmaceutical manufacturers, payers, and government organizations have partnered with HealthVerity to solve some of their most complicated use cases through transformative technologies and real-world data infrastructure. The HealthVerity IPGE platform, based on the foundational elements of Identity, Privacy, Governance, and Exchange, enables the discovery of real-world data across the broadest healthcare data ecosystem, the building of more complete and accurate patient journeys and the ability to power best-in-class analytics and applications with flexibility and ease. Together with our partners, HealthVerity has built the modern way to data for the health insights economy. To learn more about the HealthVerity IPGE platform, visit www.healthverity.com.
Jen Kaczmarczyk
Vice President of Marketing
jkaczmarczyk@healthverity.com
Complete the form to explore how synchronizing transformational technologies with the nation’s largest real-world data ecosystem can fundamentally advance the science.
Technical.ly
Philadelphia Business Journal
PHILADELPHIA, PA — (BUSINESS NEWSWIRE) — HealthVerity announced today the close of $100 million in Series D funding to accelerate the growth of its IPGE (Identity, Privacy, Governance and Exchange) platform. This latest round of funding, led by Durable Capital Partners LP, with participation from all existing investors including Flare Capital Partners, Foresite Capital and Greycroft will help HealthVerity meet the increasing demand for its critical technologies empowering the health insights economy. Beyond accelerating go-to-market initiatives, the financing will fund expansion of the already existing largest real-world data ecosystem and industry-leading patient identity resolution technology.
“We are excited to partner with HealthVerity as it continues to build the next generation of modern technologies that will support the shift towards increased real-world data governance and privacy needs within healthcare,” said Henry Ellenbogen, Managing Partner & Chief Investment Officer at Durable Capital Partners LP. “After witnessing its growth over the past few years, I believe HealthVerity is uniquely positioned to provide solutions for many of the challenges around identity, privacy and governance that will help life sciences, payers and government agencies power secure and private data exchange across an array of patient-centric use cases. It has the potential to be a significant company.”
“Durable’s goal of partnering with high-growth, long-term transformative companies directly aligns with our mission at HealthVerity, where we have been consistent since our inception in our strategy and approach to evolving the healthcare data ecosystem and supporting our clients as they shift towards patient-centricity,” said Andrew Kress, CEO at HealthVerity. “We are so pleased to have them join the HealthVerity team.“
HealthVerity’s IPGE platform provides a unified infrastructure granting more than 250 leading healthcare enterprises and more than 80% of top pharmaceutical companies the ability to confidently leverage the technical capabilities of Identity, Privacy, Governance and Exchange to discover, access and apply real-world healthcare data to a multitude of use cases. Over the past year, HealthVerity’s growth has been accompanied by the selection from the Department of Health and Human Services (HHS) to deliver Privacy Preserving Record Linkage (PPRL) integrated in the COVID-19 vaccine rollout and partnerships with the FDA and NIH on multiple COVID-19 studies.
Durable Capital Partners LP (“Durable”) is an investment manager focused on companies that have the potential to compound over time. Durable invests across private and public markets with a long-term horizon, applying deep knowledge of compounder patterns to support leaders building durable and sustainable businesses. Henry Ellenbogen, who previously was Portfolio Manager of T. Rowe Price’s New Horizon Fund, founded Durable in 2019.
Pharmaceutical manufacturers, payers, and government organizations have partnered with HealthVerity to solve some of their most complicated use cases through transformative technologies and real-world data infrastructure. The HealthVerity IPGE platform, based on the foundational elements of Identity, Privacy, Governance, and Exchange, enables the discovery of real-world data across the broadest healthcare data ecosystem, the building of more complete and accurate patient journeys and the ability to power best-in-class analytics and applications with flexibility and ease. Together with our partners, HealthVerity has built the modern way to data for the health insights economy. To learn more about the HealthVerity IPGE platform, visit www.healthverity.com.
HealthVerity
Colleen Stoker
cstoker@healthverity.com
Complete the form to explore how synchronizing transformational technologies with the nation’s largest real-world data ecosystem can fundamentally advance the science.
Gilead
PR Newswire
McKesson Ventures
